A novel hypoxia-driven gene signature that can predict the prognosis of hepatocellular carcinoma-Reference-Cited by-同舟云学术

A novel hypoxia-driven gene signature that can predict the prognosis of hepatocellular carcinoma

Published:2022-05-02 Issue:5 Volume:13 Page:12193-12210
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Zeng Zhirui¹²³,Lei Shan¹^ORCID,Wang Jingya¹,Yang Yushi⁴,Lan Jinzhi¹,Tian Qianting¹,Chen Tengxiang¹⁵,Hao Xiaojiang²³

Affiliation:

1. Guizhou Provincial Key Laboratory of Pathogenesis & Drug Research on Common Chronic Diseases, Department of Physiology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China

2. State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China

3. Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academy of Sciences, Guiyang, China

4. Department of Pathology, Affiliated Hospital of Guizhou Medical University, Guiyang, China

5. Precision Medicine Research Institute of Guizhou Medical University, Affiliated Hospital of Guizhou Medical University, Guiyang, China

Funder

the National Natural Science Foundation of China

the Guizhou Provincial High-level Overseas Talents Innovation and Entrepreneurship Selection Funding Project

the Cultivation Fund Project for Application of NSFC of the Affiliated Hospital of Guizhou Medical University

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2073943

Reference48 articles.

1. Patient‐reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases

2. Molecular therapies and precision medicine for hepatocellular carcinoma

3. Targeted therapy for hepatocellular carcinoma

4. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma

5. Role of hypoxia in cancer therapy by regulating the tumor microenvironment

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trans-resveratrol mitigates miR-204-3p mediated progression of allergic rhinitis by regulating the EGLN3/HIF-1α/IL33/ST2 signalling pathway;Phytomedicine;2024-11

2. Phytochemical Analysis and Cytotoxic Effects of Phyllanthus polygonoides Leaf Extracts on Hepatocellular Carcinoma: A Combined In-Vitro and In-Silico Approach;2024-08-19

3. Trans-Resveratrol Mitigates Mir-204-3p Mediated Progression of Allergic Rhinitis by Regulating Egln3/Hif-1α/Il33/St2 Signalling Pathway;2024

4. Identifying the programmed cell death index of hepatocellular carcinoma for prognosis and therapy response improvement by machine learning: a bioinformatics analysis and experimental validation;Frontiers in Immunology;2023-12-19

5. An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy;Aging;2023-10-06